# Enliven Therapeutics, Inc.: Form SC 13D/A, filed Apr 4, 2024

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: SC 13D/A
- Filed: 2024-04-04
- Accepted by EDGAR: Apr 4, 2024, 16:39 ET
- Period: not reported
- Accession: 0000947871-24-000350
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000094787124000350/ss3223565_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000094787124000350/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000094787124000350/ss3223565_sc13da.htm

Filed Apr 4, 2024.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000350. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.
